The world’s largest ex‑US real‑world data network.
Syntium gives life-sciences teams access to de-identified, longitudinal patient records from hospital networks in 20+ countries. The data stays in-country, harmonized to one common data model, and every cohort can be scoped in seconds before you commit.
Hold data? Become a Syntium partner →
Access is provided through partner networks. Availability varies by partner, country, modality and project.
One paragraph stating what counts as a source, what counts as a patient record, and the as-of date behind 1.1bn+ / 50+ / 20+. This is the sentence a diligence reader will ask for; it sits here under the numbers once approved.
Built for the people who use real-world data, and the institutions that hold it.
Customers and data partners want different things. Each gets its own path, its own proof and its own way to start.
Know your universe before you commit.
Access diverse, longitudinal real-world data for regulatory, epidemiology, HEOR and AI work. Scope in seconds, analyze inside a Trusted Research Environment.
- Pharma & biopharma
- CROs
- HEOR & market access
- AI & tech
- Academia
Your data, discoverable. Never exposed.
Put your data to work for your patients and the world, with sovereignty guarantees, benefit-sharing and Syntium doing the heavy lifting.
- Hospitals
- Health systems
- EMR vendors
- Registries
- National programs
Medicine’s evidence base still describes a small part of the world.
Most real-world evidence is built on US and European data, feasibility still takes weeks, and some of the world’s most diverse data is locked inside national borders.
Western-only evidence
Real-world evidence is dominated by US claims and European registries, leaving most of the world’s patients out of the data that shapes their care.
Slow feasibility
Sizing a patient population can take weeks of back-and-forth with data vendors before a study can even be designed.
Data trapped in-country
Hospitals hold rich longitudinal records, but data-sovereignty rules rightly keep them in jurisdiction and out of reach of conventional data models.
One network. One platform. Data that never has to leave home.
Syntium is the data platform. The Scoping Engine is the front door. The Trusted Research Environment is where the work happens. Nexa sits alongside, so you can act on what you find.
Six reasons Syntium is different.
Scale
Access to de-identified, longitudinal patient records across 50+ sources in 20+ countries.
Diversity
The majority of records come from outside the US and Europe. Not a Western-only view.
Depth
Longitudinal, episodic and multimodal, harmonized to one common data model.
Sovereignty
Federated in-country hubs. Data stays in jurisdiction, countries keep ownership, and populations share in the value.
Speed
The Syntium Scoping Engine sizes patient universes in seconds, not days.
Trusted delivery
Per-project Trusted Research Environments with a full analytic stack. Only approved aggregate outputs leave the boundary.
A network built where medicine’s data gaps are widest.
Syntium partners with hospital networks, health systems, registries and national programs across 20+ countries, with the majority of records coming from outside the US and Europe.
Representative network countries shown. Availability varies by partner, country and modality. Partner and client names are never published.
Know your universe before you commit.
Pick datasets, set criteria and count in seconds. See the distributions, then save and export your scope. Feasibility becomes a workflow you live in, not a one-off request.
A self-serve patient-universe sizer across the whole network, with counts and distributions in seconds.
Your data, discoverable. Demand surfaces through blinded aggregate counts only, with no patient-level or identity exposure.
Scope the cohort in Syntium. Engage it through Nexa.
Two Xeomics businesses, one continuous workflow from evidence to action.
Find and size the cohort
Scope patient universes across the network in the Scoping Engine, then analyze them inside a Trusted Research Environment.
Reach the people behind it
Recruit into studies, capture patient-reported outcomes and run adherence programs through Nexa’s point-of-care network of clinicians and patients.
Trust is designed in, not bolted on.
For the populations medicine overlooked, trust is the product. Every safeguard below applies to every partner and every project.
- De-identified at source, before data is used for any research.
- GDPR and local law, with consent and linkage permissions respected in every jurisdiction.
- Data stays in jurisdiction, hosted in Syntium Cloud in-country.
- No re-identification, ever.
- Only approved aggregate outputs leave the Trusted Research Environment.
- Governance review built into every project.
Names stay private
We never publish partner or client names. References are available under NDA as part of a briefing.
Delivered work, on request
Details of studies, feasibility assessments and regulatory work supported are shared during a briefing.
Replaces the “Track record” card above when the figures are approved.
Led by people who have built real-world data businesses before.
Former Global Lead of Secondary Data, OPEN Health; 20 years in real-world data.
Former Chief Data Officer, Publicis and Capgemini.
Start with the path that fits.
Scope a cohort, request a briefing, or bring your institution into the network.
Or email syntium@xeomics.com